Browse > Article
http://dx.doi.org/10.15204/jkobgy.2015.28.1.029

In Vitro Antibacterial Effects of Yeonkyokeumpae-jeon against Escherichia coli  

Han, Sang-Kyum (Dept. of Korean Obstetric & Gynecology, College of Korean Medicine, Deagu Haany University)
Kim, Dong-Chul (Dept. of Korean Obstetric & Gynecology, College of Korean Medicine, Deagu Haany University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.28, no.1, 2015 , pp. 29-45 More about this Journal
Abstract
Objectives: The object of this study was to observe the in vitro antibacterial effects of Yeonkyokeumpae-jeon (YKKPJ) have been used for treating various gynecological diseases including mastitis in Korea, and individual six kinds of herbal composition aqueous extracts - Forsythiae Fructus (FF), Millettiae Caulis (MC), Lonicerae Flos (LF), Fritillaria Thunbergii Bulb (FT), Taraxci Herba (TH) and Prunellae Spica (PS) against E. coli. Methods: Antibacterial activities against E. coli of YKKPJ, FF, MC, LF, FT, TH and PS aqueous extracts were detected using standard agar microdilution methods. In addition, the effects on the bacterial growth curve were also monitored at MIC and $MIC{\times}2$ levels. The effects on the intracellular killing and bacterial invasion of individual test materials were also observed using Raw 264.7 and MCF-7. The results were compared with ciprofloxacin, a second generation of quinolone antibiotics in the present study. Results: MIC of YKKPJ, FF, MC, LF, FT, TH, PS aqueous extracts against E. coli were detected as $0.039{\pm}0.013mg/ml$, $0.064{\pm}0.033mg/ml$, $0.108{\pm}0.053mg/ml$, $0.078{\pm}0.027mg/ml$, $16.250{\pm}8.385mg/ml$, $15.625{\pm}9.375mg/ml$, $0.254{\pm}0.131mg/ml$, repectively. YKKPJ, FF, MC, LF, FT, TH, PS aqueous extracts showed antibacterial effects against to E. coli, except for FT and TH, which were showed negligible antibacterial effects, respectively. In addition, ciprofloxacin with YKKPJ, FF, MC, LF and PS aqueous extracts also showed marked dosage-dependent inhibition of bacterial growth, and favorable inhibitory effects on the both bacterial invasion and intracellular killing assays using MCF-7 and Raw 264.7 cells were detected in this experiment. Conclusions: The results obtained in this study suggest that traditional polyherbal formula YKKPJ aqueous extracts showed more favorable antibacterial activities as compared to individual six kinds of herbal composition aqueous extracts. The antibacterial effects of YKKPJ against E. coli considered as results of complicated synergic effects of their six kinds of herbal components rather than simple antibacterial effects of single herbal components. It means, YKKPJ aqueous extracts may show potent anti-infectious effects against E. coil for mastitis.
Keywords
Yeonkyokeumpae-jeon; Escherichia coli; Mastitis; Ciprofloxacin; Raw 264.7; MCF-7;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Egerbacher M, et al. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res. 2001;62:704-8.   DOI   ScienceOn
2 Seral C, et al. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob Agents Chemother. 2003;47:2283-92.   DOI   ScienceOn
3 Pispirigos K, Chrysanthopoulos K. Evaluation of cardiac subacutetoxicity of ciprofloxacin in rats using serum biochemical parameters. Arzneimittelforshung. 2001;51:582-7.
4 Pons R, Escutia B. Ciprofloxacininduced vasculitis with cutaneous and renal involvment. Nefrologia. 2001;21:209-12.
5 Williams RJ III, et al. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28:364-9.   DOI
6 Heo J. Dongeuibogam. Seoul:Hanmi Medical Publishing. 2008:384.
7 Zinner SH, et al. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model. Int J Antimicrob Agents. 2004;24:173-7.   DOI   ScienceOn
8 Sordillo LM, et al. Immunology of the mammary gland, In: Proceedings of the Symposium on Bovine Immunology. J Dairy Sci. 1997;80:1851-65.   DOI   ScienceOn
9 Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63:174-229.
10 Dziewanowska K, et al. Fibronectin binding protein and host cell tyrosine kinase are required for internalisation of Staphylococcus aureus by epithelial cells. Infect Immunol. 1999;67:4673-8.
11 Levene A. Pathological factors influencing excision of tumours in the head and neck. Part I. Clin Otalary. 1981;6:145-51.   DOI
12 Cuffini AM, et al. Enhanced Staphylococcus aureus susceptibility to immuno-defense induced by sub-inhibitory and bactericidal concentration of imipenem. J Antimicrob Chemotherp. 1993;31:559-68.   DOI   ScienceOn
13 Pfaller MA, et al. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother. 1992;36:1805-9.   DOI   ScienceOn
14 Tenover FC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 1998;36:1020-7.
15 Ludbrook J. Update: microcomputer statistics packages. A personal view. Clin Exp Pharmacol Physiol. 1997;24:294-6.   DOI   ScienceOn
16 Kim OY. Epidemiological Study of Suppurative disease of the breast in Korean women. Annals of Surgical Treatment and Research. 1973;15:11-8.
17 Foxman B, et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol. 2002;155:103-14.   DOI   ScienceOn
18 Gillespie SH, et al. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol. 2001;50:565-70.   DOI
19 Okamoto R, et al. Detection of genes regulating beta-lactamase production in Enterococcus faecalis and Staphylococcus aureus. Antimicrob Agents Chemother. 1996;40:2550-4.
20 Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob A gents. 2000;16:5-15.   DOI   ScienceOn
21 Qu H, et al. Isoforsythiaside, an antioxidant and antibacterial phenylethanoid glycoside isolated from Forsythia suspensa. Bioorg Chem. 2012;40:87-91.   DOI   ScienceOn
22 Bachoual R, et al. Single or double mutation alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist. 2001;7:257-61.   DOI   ScienceOn
23 Korean Medical Obstetrics and Gynecology compilation committee. Korean Medical Obstetrics and Gynecology II. Seoul: Jungdam. 2007:446-9.
24 Gae Bin J. Gyungakjeonseo1. Seoul: Dongwonmunhwasa. 2004:560.
25 Hwang JT, et al. Isolation and identification of antifungal compounds from Spatholobus suberectus Dunn. Journal of the Korean Society of Pesticide Science. 2012;16:209-16.   DOI   ScienceOn
26 Xiong J, et al. Screening and identification of the antibacterial bioactive compounds from Lonicera japonica Thunb. leaves. Food Chem. 2013;138:327-33.   DOI   ScienceOn
27 Shin YK, et al. Evaluation of Antimicrobial, Antithrombin, and Antioxidant Activity of Fritillaria thunbergii Miquel. Journal of Life Science. 2009;19:1245-50.   DOI   ScienceOn
28 Janssen AM, et al. Antimicrobial activity of essential oils: a 1976-86 literature review. Aspects of the test methods. Planta Med. 1987;53:395-8.   DOI   ScienceOn
29 Oh C, et al. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol J. 2011;8:188.   DOI   ScienceOn
30 Pfaller MA, et al. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol. 1988;26:1437-41.
31 Almeida RA, et al. Staphylococcus aureus invasion of bovine mammary epithelial cells. J Dairy Sci. 1996;79:1021-6.   DOI   ScienceOn
32 Chen CY, et al. Methicillin-resistant Staphylococcus aureus infections may not impede the success of ultrasound-guided drainage of puerperal breast abscesses. J Am Coll Surg. 2010;210:148-54.   DOI   ScienceOn
33 Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;78:727-31.
34 Korean Breast Cancer Society. The Breast. Seoul:Ilchokak. 1999:47-8.
35 Wambach KA. Lactation mastitis: a descriptive study of the experience. J Hum Lact. 2003;19:24-34.   DOI
36 Lawrence RA, Lawrence RM. Management of the mother-infant nursing couple. In: Breastfeeding: A Guide for the Medical Profession. 6th ed. St. Louis: Mosby. 2005:255-316.
37 Zhu W, et al. β-Glucan modulates the lipopolysaccharide-induced innate immune response in rat mammary epithelial cells. Int Immunopharmacol. 2013;15:457-65.   DOI   ScienceOn
38 Dogan B, et al. Phylogroup and lpfA influence epithelial invasion by mastitis associated Escherichia coli. Vet Microbiol. 2012;159:163-70.   DOI   ScienceOn
39 Ackermann G, et al. Resistant to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother. 2001;45:2348-53.   DOI   ScienceOn
40 Burvenich C, et al. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res. 2003;34:521-64.   DOI   ScienceOn